SG10201606442QA - Method for treating schizophrenia - Google Patents

Method for treating schizophrenia

Info

Publication number
SG10201606442QA
SG10201606442QA SG10201606442QA SG10201606442QA SG10201606442QA SG 10201606442Q A SG10201606442Q A SG 10201606442QA SG 10201606442Q A SG10201606442Q A SG 10201606442QA SG 10201606442Q A SG10201606442Q A SG 10201606442QA SG 10201606442Q A SG10201606442Q A SG 10201606442QA
Authority
SG
Singapore
Prior art keywords
treating schizophrenia
schizophrenia
treating
Prior art date
Application number
SG10201606442QA
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of SG10201606442QA publication Critical patent/SG10201606442QA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG10201606442QA 2011-08-05 2012-08-03 Method for treating schizophrenia SG10201606442QA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161515418P 2011-08-05 2011-08-05

Publications (1)

Publication Number Publication Date
SG10201606442QA true SG10201606442QA (en) 2016-09-29

Family

ID=47627335

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201606442QA SG10201606442QA (en) 2011-08-05 2012-08-03 Method for treating schizophrenia

Country Status (18)

Country Link
US (2) US8592483B2 (zh)
EP (1) EP2739278A4 (zh)
JP (2) JP6193230B2 (zh)
KR (1) KR20140076551A (zh)
CN (2) CN103841966A (zh)
AR (1) AR087468A1 (zh)
AU (2) AU2012293157A1 (zh)
BR (1) BR112014002712A8 (zh)
CA (1) CA2842455A1 (zh)
HK (1) HK1252353A1 (zh)
IL (2) IL230552A (zh)
MX (1) MX359697B (zh)
NZ (1) NZ620300A (zh)
RU (1) RU2648474C2 (zh)
SG (1) SG10201606442QA (zh)
TW (2) TWI619497B (zh)
WO (1) WO2013022079A1 (zh)
ZA (1) ZA201400707B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103450128B (zh) * 2013-08-15 2015-04-08 河南中帅医药科技股份有限公司 用于治疗青光眼的前列腺素类似物中间体Corey醛的制备方法
US20150057351A1 (en) * 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain
WO2020217656A1 (ja) 2019-04-24 2020-10-29 ヤマハ発動機株式会社 鞍乗型車両

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5225439A (en) 1987-01-28 1993-07-06 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5428062A (en) 1987-01-28 1995-06-27 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5591887A (en) 1987-04-30 1997-01-07 R-Tech Ueno, Ltd. Prostaglandins of the F series
CA1324129C (en) 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
DE3850676T2 (de) * 1987-09-18 1994-11-03 R Tech Ueno Ltd Hypotensive okulare Mittel.
CA2030345C (en) 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
TW224942B (zh) 1990-04-04 1994-06-11 Adka Ueno Kk
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
ES2182088T3 (es) 1996-06-10 2003-03-01 Sucampo Ag Antagonista de la endotelina.
TWI225398B (en) * 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
ITRM20010356A1 (it) * 2001-06-21 2002-12-23 Sigma Tau Ind Farmaceuti "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina.
IL157751A0 (en) * 2003-02-28 2004-03-28 Yissum Res Dev Co New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them
US20040224995A1 (en) * 2003-05-09 2004-11-11 University Of North Texas Health Science Center At Fort Worth Neuroprotective effects of PPARy agonists against cellular oxidative insults
JP5147404B2 (ja) * 2005-01-27 2013-02-20 スキャンポ・アーゲー 中枢神経系障害の処置のための方法および組成物
TWI432201B (zh) * 2005-03-04 2014-04-01 Sucampo Ag 11-去氧基-前列腺素化合物用於治療週邊血管疾病之用途
US7211703B2 (en) * 2005-04-27 2007-05-01 Calgon Carbon Corporation Method of separating E and Z isomers of an alkene alcohol and derivatives thereof
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
BRPI0814115B8 (pt) * 2007-07-19 2021-05-25 R Tech Ueno Ltd composição farmacêutica compreendendo o composto 11-deóxi-prostaglandina e método para estabilizar o composto
JP6023082B2 (ja) * 2011-01-24 2016-11-09 インセプタム リサーチ アンド セラピューティクス，インク． 精神神経性の疾病を処置するためのプロスタグランジンを含む組成物

Also Published As

Publication number Publication date
TWI619497B (zh) 2018-04-01
TW201808302A (zh) 2018-03-16
RU2014108423A (ru) 2015-09-10
MX359697B (es) 2018-10-08
AU2017203092A1 (en) 2017-06-01
US20140031428A1 (en) 2014-01-30
TW201316992A (zh) 2013-05-01
WO2013022079A1 (en) 2013-02-14
NZ620300A (en) 2015-09-25
JP6193230B2 (ja) 2017-09-06
JP2017222708A (ja) 2017-12-21
IL230552A (en) 2017-09-28
CN103841966A (zh) 2014-06-04
AR087468A1 (es) 2014-03-26
AU2017203092B2 (en) 2018-11-08
BR112014002712A2 (pt) 2017-06-13
EP2739278A1 (en) 2014-06-11
IL254289A0 (en) 2017-10-31
US20130035393A1 (en) 2013-02-07
RU2648474C2 (ru) 2018-03-26
JP2014527048A (ja) 2014-10-09
CN107903173A (zh) 2018-04-13
CA2842455A1 (en) 2013-02-14
US8592483B2 (en) 2013-11-26
BR112014002712A8 (pt) 2017-06-20
IL230552A0 (en) 2014-03-31
TWI619498B (zh) 2018-04-01
MX2014001409A (es) 2014-05-28
ZA201400707B (en) 2014-11-26
KR20140076551A (ko) 2014-06-20
HK1252353A1 (zh) 2019-05-24
EP2739278A4 (en) 2015-03-18
AU2012293157A1 (en) 2014-03-13

Similar Documents

Publication Publication Date Title
HRP20180237T1 (hr) Metode za liječenje hcv-a
ZA201400005B (en) Method for treating eczema
EP2698464A4 (en) WASHING METHOD
PL2685961T3 (pl) Sposób leczenia urazu neurologicznego
HK1201040A1 (zh) 治療骨質疏鬆症的方法
EP2788541A4 (en) METHOD FOR CONTROLLING A DRYER
ZA201208219B (en) Method for treating wasterwater
ZA201400544B (en) Method for treating industrial waste
EP2650276A4 (en) PROCESS FOR PRODUCTION OF -FLUOROALCOOL
HK1202297A1 (zh) 治療痤瘡的方法
PL2691219T3 (pl) Sposób obróbki tekstyliów technicznych
HRP20181649T1 (hr) Metoda liječenja osteoporoze
HK1252353A1 (zh) 治療精神分裂症的方法
EP2743258A4 (en) PROCESS FOR PURIFYING LEVO-OXIRACETAM
EP2694077A4 (en) METHOD FOR TREATING ASTHENOPY
IL228744A0 (en) A method for treating diseases related to interferon alpha
HK1209040A1 (zh) 用於治療前庭毒性的方法
GB201105523D0 (en) Treatment method